Peripheral facial paralysis during the COVID-19 pandemic

Basit Öğe Kaydı
dc.authorid0000-0001-8990-0651en_US
dc.authorid0000-0001-5786-5337en_US
dc.contributor.authorAydın, Şükrü
dc.contributor.authorFırat Koca, Çiğdem
dc.contributor.authorÇelik, Turgut
dc.contributor.authorKelleş, Mehmet
dc.contributor.authorYaşar, Şeyma
dc.date.accessioned2022-07-21T11:29:27Z
dc.date.available2022-07-21T11:29:27Z
dc.date.issued2022en_US
dc.departmentMTÖ Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.descriptionReceived 03 November 2021; Accepted 19 January 2022.en_US
dc.descriptionCopyright@Author(s) - Available online at www.medicinescience.org Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.en_US
dc.description.abstractThe mechanism surrounding idiopathic peripheral facial nerve paralysis remains unclear, though viral infections and even immunizations have been suspected of its origin. Thus, the relationship between COVID-19 and facial paralysis should be studied. With this research, we aimed to investigate the characteristics of facial paralysis during the COVID-19 illness as well as the relationship between facial paralysis and COVID-19, the length of time needed for recovery, concurrence with COVID-19 infection, and whether facial paralysis is a late complication or initial symptom of the disease. Forty-five patients thought to have had idiopathic peripheral facial paralysis were included in the study. Pure tone audiometry, COVID-19 PCR tests, and contrast-enhanced ear MRIs were performed on all participants. A standard prednisolone treatment protocol was followed. Participants were monitored for one month; we recorded whether they had COVID-19 previously, initially, or contracted it within the one-month testing period. At the same time, facial paralysis recovery rates were recorded and used in statistical analyses. PCR test at initial admission was reported as positive for COVID-19 in only one participant (2.2%). We discovered an improvement delay regarding facial paralysis in participants who had had COVID-19 previously (p<0.001). Prednisolone therapy used for peripheral facial paralysis did not pose an additional risk for COVID-19. Having had COVID-19 previously may cause delayed recovery of peripheral facial paralysis. Peripheral facial paralysis may be both a late manifestation as well as an early symptom of COVID-19.en_US
dc.identifier.citationAydin, S., Koca, C. F., Celik, T., Kelles, M., & Yasar, S. (2022). Peripheral facial paralysis during the COVID-19 pandemic. Medicine, 11(2), 666-71.en_US
dc.identifier.doi10.5455/medscience.2021.11.365
dc.identifier.endpage671en_US
dc.identifier.issue2en_US
dc.identifier.startpage666en_US
dc.identifier.urihttps://doi.org/10.5455/medscience.2021.11.365
dc.identifier.urihttps://hdl.handle.net/20.500.12899/1166
dc.identifier.volume11en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.institutionauthorFırat Koca, Çiğdem
dc.institutionauthorKelleş, Mehmet
dc.language.isoenen_US
dc.publisherİnönü Üniversitesien_US
dc.relation.ispartofMedicine Scienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectPandemicen_US
dc.subjectPeripheral facial paralysisen_US
dc.subjectPrednisolone therapyen_US
dc.subjectSARS-CoV-2en_US
dc.titlePeripheral facial paralysis during the COVID-19 pandemicen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Şükrü Aydın - Makale Dosyası.pdf
Boyut:
780.56 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Full Text / Tam Metin
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Cerrahi Tıp Bilimleri Bölümü Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu